Intranasal midazolam in patients with status epilepticus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9055784.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The patient in status epilepticus presents many challenges to the emergency physician. IV access is frequently difficult to achieve, and prolonged attempts at access can jeopardize the patient and endanger the caregiver. We present two cases in which the administration of intranasal midazolam appeared to successfully terminate status epilepticus. No adverse effects were noted. Studies are needed to clarify the safety, optimal dosing, and clinical utility of this treatment modality.
Medical subject headings
- Anticonvulsants
- Hypnotics and Sedatives
- Midazolam
- Status Epilepticus